Why TELA Bio Inc (TELA) Stock Is Rising
As of 2026-09-09, TELA Bio Inc (TELA) has a next-year EPS growth estimate of 34.22%. Featured in our EPS revision report on 2026-09-09.
Why TELA Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised TELA Bio Inc's next-year EPS growth estimate from 25.80% to 34.22% on 2026-09-03.
- ·Current-Year Growth: Projected at 17.69%, supporting the forward estimate revision.
News Context
The primary driver is the September 3 upgrade to next-year EPS growth from 25.8% to 34.2%. This followed TELA Bio’s Q2 2026 earnings release, though headlines highlight only strategic navigation of PRS headwinds, not an explicit beat or guidance raise. No evidence shows further upward revisions since, so the rise appears tied to that single estimate upgrade rather
Generated 2026-09-09 · news as of 2026-09-09
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 34.22%
- EPS growth this year
- 17.69%
- EPS next quarter (est)
- -$0.16
- Last price
- $0.90
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-09 | 34.22% | 17.69% | -$0.16 | $0.90 |
| 2026-09-08 | 34.22% | 17.69% | -$0.16 | $0.83 |
| 2026-09-07 | 34.22% | 17.69% | -$0.16 | $0.82 |
| 2026-09-06 | 34.22% | 17.69% | -$0.16 | $0.82 |
| 2026-09-04 | 34.22% | 17.69% | -$0.16 | $0.82 |
| 2026-09-03 | 34.22% | 17.69% | -$0.16 | $0.78 |
| 2026-09-02 | 25.80% | 16.97% | -$0.15 | $0.75 |
| 2026-09-01 | 25.80% | 16.97% | -$0.15 | $0.79 |
| 2026-08-31 | 25.80% | 16.97% | -$0.15 | $0.74 |
| 2026-08-30 | 25.80% | 16.97% | -$0.15 | $0.70 |
| 2026-08-29 | 25.80% | 16.97% | -$0.15 | $0.70 |
| 2026-08-28 | 25.80% | 16.97% | -$0.15 | $0.70 |
| 2026-08-27 | 25.80% | 16.97% | -$0.15 | $0.65 |
| 2026-08-26 | 25.80% | 16.97% | -$0.15 | $0.69 |
| 2026-08-25 | 25.80% | 16.97% | -$0.15 | $0.70 |
| 2026-08-24 | 25.80% | 16.97% | -$0.15 | $0.65 |
| 2026-08-23 | 25.80% | 16.97% | -$0.15 | $0.65 |
| 2026-08-21 | 25.80% | 16.97% | -$0.15 | $0.65 |
| 2026-08-20 | 25.80% | 16.97% | -$0.15 | $0.64 |
| 2026-08-19 | 25.80% | 16.97% | -$0.15 | $0.65 |
| 2026-08-18 | 25.80% | 16.97% | -$0.15 | $0.64 |
| 2026-08-17 | 25.80% | 16.97% | -$0.15 | $0.65 |
| 2026-08-16 | 25.80% | 16.97% | -$0.15 | $0.64 |
| 2026-03-25 | 36.40% | N/A | N/A | $0.69 |
| 2026-03-24 | 30.81% | N/A | N/A | $0.76 |
| 2026-03-24 | 30.81% | N/A | N/A | $0.76 |
| 2026-03-24 | 30.81% | N/A | N/A | $0.76 |
| 2026-03-23 | 30.81% | N/A | N/A | $0.83 |
| 2026-03-20 | 30.81% | N/A | N/A | $0.78 |
| 2026-03-19 | 30.81% | N/A | N/A | $0.75 |
Reports Featuring TELA
Recent News
- TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...GuruFocus.com
- TELA Bio, Inc. Q2 2026 Earnings Call SummaryMoby
- TELA Bio Reports Second Quarter 2026 Financial ResultsGlobeNewswire
- Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% UpsideGuruFocus.com
- TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ...GuruFocus.com
- TELA Bio Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead Of EarningsGuruFocus.com
Screen Performance
Aggregate stats across all 2031 tickers our top-EPS-revision screen has flagged over the past 161 days.
- Median return since detection
- +1.5%
- % of tickers in the green
- 53%
- Median return on winners
- +21.3%
- Large revisions captured
- 1682
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did TELA Bio Inc (TELA) stock go up recently?▾
TELA Bio Inc (TELA) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 25.80% to 34.22% on 2026-09-03. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is TELA Bio Inc's next-year EPS growth estimate?▾
As of 2026-09-09, TELA Bio Inc (TELA) has a next-year EPS growth estimate of 34.22%, based on analyst consensus.
When was the latest EPS estimate revision for TELA?▾
The most recent revision occurred on 2026-09-03, when analysts adjusted the next-year EPS growth estimate from 25.80% to 34.22%.
What sector and industry does TELA Bio Inc belong to?▾
TELA Bio Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TELA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. TELA Bio Inc (TELA) appears here because it was detected by our daily top-EPS-revision-performer screen.